Cargando…

Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients

BACKGROUND: To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity. METHOD: A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Lin-sen, Li, Xin-yue, Wang, Hong-rong, Zhan, Jing-jing, Chen, Dong, Wang, Yu-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092871/
https://www.ncbi.nlm.nih.gov/pubmed/30107802
http://dx.doi.org/10.1186/s12955-018-0984-x
_version_ 1783347610016284672
author Feng, Lin-sen
Li, Xin-yue
Wang, Hong-rong
Zhan, Jing-jing
Chen, Dong
Wang, Yu-feng
author_facet Feng, Lin-sen
Li, Xin-yue
Wang, Hong-rong
Zhan, Jing-jing
Chen, Dong
Wang, Yu-feng
author_sort Feng, Lin-sen
collection PubMed
description BACKGROUND: To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity. METHOD: A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the preliminary version of the CSPDS, then the reliability, the validity and the acceptability of the final version of CSPDS were assessed. RESULTS: This CSPDS contained 14 items classified into 3 subscales: social withdrawal with 7 items, stigma with 4 and self-deprecation with 3. Good validity (χ(2)/df = 1.216, GFI = 0.935, AGFI = 0.903, I-CVIs> 0.80) and good reliability (Cronbach’s alpha = 0.829, Spearman-Brown coefficient = 0.827, test-retest reliability coefficient = 0.944) were found. The completion time was 6.06 ± 1.80 min. Participants who were female and reported poor self-rated health tended to have higher CSPDS scores (P <  0.05). CONCLUSIONS: The results indicated that this CSPDS could be used to assess the level of self-perceived discrimination and to preliminarily screen perceived discrimination among Chinese cancer patients, especially in Southwest China. It may provide a basis for scientific assessment of targeted patient education, psychological counseling, social interventions, and psychotherapy in the future.
format Online
Article
Text
id pubmed-6092871
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60928712018-08-20 Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients Feng, Lin-sen Li, Xin-yue Wang, Hong-rong Zhan, Jing-jing Chen, Dong Wang, Yu-feng Health Qual Life Outcomes Research BACKGROUND: To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity. METHOD: A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the preliminary version of the CSPDS, then the reliability, the validity and the acceptability of the final version of CSPDS were assessed. RESULTS: This CSPDS contained 14 items classified into 3 subscales: social withdrawal with 7 items, stigma with 4 and self-deprecation with 3. Good validity (χ(2)/df = 1.216, GFI = 0.935, AGFI = 0.903, I-CVIs> 0.80) and good reliability (Cronbach’s alpha = 0.829, Spearman-Brown coefficient = 0.827, test-retest reliability coefficient = 0.944) were found. The completion time was 6.06 ± 1.80 min. Participants who were female and reported poor self-rated health tended to have higher CSPDS scores (P <  0.05). CONCLUSIONS: The results indicated that this CSPDS could be used to assess the level of self-perceived discrimination and to preliminarily screen perceived discrimination among Chinese cancer patients, especially in Southwest China. It may provide a basis for scientific assessment of targeted patient education, psychological counseling, social interventions, and psychotherapy in the future. BioMed Central 2018-08-14 /pmc/articles/PMC6092871/ /pubmed/30107802 http://dx.doi.org/10.1186/s12955-018-0984-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Feng, Lin-sen
Li, Xin-yue
Wang, Hong-rong
Zhan, Jing-jing
Chen, Dong
Wang, Yu-feng
Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
title Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
title_full Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
title_fullStr Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
title_full_unstemmed Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
title_short Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
title_sort development and validation of the cancer self-perceived discrimination scale for chinese cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092871/
https://www.ncbi.nlm.nih.gov/pubmed/30107802
http://dx.doi.org/10.1186/s12955-018-0984-x
work_keys_str_mv AT fenglinsen developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients
AT lixinyue developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients
AT wanghongrong developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients
AT zhanjingjing developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients
AT chendong developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients
AT wangyufeng developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients